Chemoinformaics analysis of (3-ETHENYL-2,5-DIMETHYLHEX-4-EN-2-YL) ACETATE
Molecular Weight | 196.29 | nRot | 4 |
Heavy Atom Molecular Weight | 176.13 | nRig | 7 |
Exact Molecular Weight | 196.146 | nRing | 0 |
Solubility: LogS | -2.238 | nHRing | 0 |
Solubility: LogP | 1.938 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 34.9799 |
nHD | 0 | BPOL | 22.6681 |
QED | 0.596 |
Synth | 1.293 |
Natural Product Likeliness | -0.274 |
NR-PPAR-gamma | 0.073 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.006 |
HIA | 0.005 |
CACO-2 | -4.352 |
MDCK | 0.0000549 |
BBB | 0.976 |
PPB | 0.455232 |
VDSS | 0.571 |
FU | 0.341258 |
CYP1A2-inh | 0.834 |
CYP1A2-sub | 0.352 |
CYP2c19-inh | 0.734 |
CYP2c19-sub | 0.711 |
CYP2c9-inh | 0.214 |
CYP2c9-sub | 0.315 |
CYP2d6-inh | 0.01 |
CYP2d6-sub | 0.312 |
CYP3a4-inh | 0.041 |
CYP3a4-sub | 0.407 |
CL | 12.557 |
T12 | 0.888 |
hERG | 0.035 |
Ames | 0.075 |
ROA | 0.054 |
SkinSen | 0.449 |
Carcinogencity | 0.287 |
EI | 0.958 |
Respiratory | 0.07 |
NR-Aromatase | 0.006 |
Antiviral | No |
Prediction | 0.671769 |